These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1549932)

  • 1. Hemodynamic effects of vasopressin antagonism and angiotensin I converting enzyme inhibition during halothane anesthesia in sheep.
    Ullman JE; Hjelmqvist H; Rundgren M; Leksell LG
    Acta Anaesthesiol Scand; 1992 Feb; 36(2):132-7. PubMed ID: 1549932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance to haemorrhage during vasopressin antagonism and/or captopril treatment in conscious sheep.
    Ullman JE; Hjelmqvist H; Lundberg JM; Rundgren M
    Acta Physiol Scand; 1992 Dec; 146(4):457-65. PubMed ID: 1492563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin and angiotensin II in blood pressure control during isoflurane anesthesia in rats.
    Ullman J
    Acta Anaesthesiol Scand; 1999 Sep; 43(8):860-5. PubMed ID: 10492417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical studies with a vascular vasopressin antagonist.
    Waeber B; Nussberger J; Hofbauer KG; Nicod P; Brunner HR
    J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S111-6. PubMed ID: 2434764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin and renin-angiotensin maintain arterial pressure during PEEP in nonexpanded, conscious dogs.
    Kaczmarczyk G; Vogel S; Krebs M; Bünger H; Scholz A
    Am J Physiol; 1996 Nov; 271(5 Pt 2):R1396-402. PubMed ID: 8945979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats.
    Gardiner SM; Kemp PA; March JE; Bennett T
    Br J Pharmacol; 1996 Dec; 119(8):1619-27. PubMed ID: 8982510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central and peripheral vasopressin interact differently with sympathetic nervous system and renin-angiotensin system in renal hypertensive rabbits.
    Kumagai H; Suzuki H; Ichikawa M; Matsumura Y; Jimbo M; Ryuzaki M; Saruta T
    Circ Res; 1993 Jun; 72(6):1255-65. PubMed ID: 8495554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II and vasopressin are involved in the defense system against anaphylactic hypotension in anesthetized rats.
    Wang M; Shibamoto T; Kuda Y; Sun L; Tanida M; Kurata Y
    Eur J Pharmacol; 2014 May; 731():38-43. PubMed ID: 24650734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin and angiotensin II contribute equally to the increased afterload in rabbits with heart failure.
    Arnolda L; McGrath BP; Johnston CI
    Cardiovasc Res; 1991 Jan; 25(1):68-72. PubMed ID: 2054832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition in pregnant sheep during late gestation.
    Forhead AJ; Whybrew K; Hughes P; Broughton Pipkin F; Sutherland M; Fowden AL
    Br J Pharmacol; 1996 Sep; 119(2):393-401. PubMed ID: 8886426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin and ANG II in the control of ACTH secretion and arterial and atrial pressures.
    Brooks VL
    Am J Physiol; 1989 Feb; 256(2 Pt 2):R339-47. PubMed ID: 2537037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. During acute hypercapnia vasopressin inhibits an angiotensin drive to ventilation in conscious dogs.
    Walker JK; Jennings DB
    J Appl Physiol (1985); 1995 Sep; 79(3):786-94. PubMed ID: 8567518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Captopril improves postresuscitation hemodynamics protective against pulmonary embolism by activating the ACE2/Ang-(1-7)/Mas axis.
    Xiao HL; Li CS; Zhao LX; Yang J; Tong N; An L; Liu QT
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1159-1169. PubMed ID: 27449068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of central angiotensin II type 1 receptors in LPS-induced systemic vasopressin release and blood pressure regulation in rats.
    Shimizu F; Kasai T; Takamata A
    J Appl Physiol (1985); 2009 Jun; 106(6):1943-8. PubMed ID: 19359612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effect of renin inhibition and angiotensin-converting enzyme inhibition in ovine heart failure.
    Fitzpatrick MA; Rademaker MT; Charles CJ; Yandle TG; Espiner EA; Ikram H; Nussberger J
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):169-75. PubMed ID: 1376784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of V1-vasopressin receptor blockade on arterial pressure in conscious rats with cirrhosis and ascites.
    Claria J; Jiménez W; Arroyo V; La Villa G; López C; Asbert M; Castro A; Gaya J; Rivera F; Rodés J
    Gastroenterology; 1991 Feb; 100(2):494-501. PubMed ID: 1824629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal hemodynamic response to ureteral obstruction during converting enzyme inhibition.
    Frøkiaer J; Djurhuus JC; Nielsen M; Pedersen EB
    Urol Res; 1996; 24(4):217-27. PubMed ID: 8873380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure responses to substances interfering with nitric oxide formation, cyclooxygenase and converting enzyme activities and vasopressin V1 receptors blockade in conscious spontaneously hypertensive and normotensive rats.
    Januszewicz A; Lapiński M; Styś T; Styś A; Loń S
    Pol J Pharmacol; 1994; 46(3):153-61. PubMed ID: 8000447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.